查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1610027

神经痛治疗市场规模、份额、趋势分析报告：按治疗、按最终用途、按地区、细分市场预测，2025-2030 年

Neuralgia Treatment Market Size, Share & Trends Analysis Report By Treatment (Drug Based, Surgery), By End Use (Hospital & Clinics, Ambulatory Surgery Centers), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

神经痛治疗市场的成长与趋势

预计2030年全球神经痛治疗市场规模将达34.3亿美元，2025年至2030年复合年增长率预计为6.7%。老年人口的增加、三叉神经痛发生率的增加以及糖尿病盛行率的增加是推动市场的关键因素。神经痛是神经损伤或发炎引起的灼痛、刺痛。

慢性神经疼痛可由多种因素引起，包括感染疾病、糖尿病、老龄化、多发性硬化症或损害保护某些神经的髓鞘的类似疾病。压迫三叉神经的肿瘤也会引起这种疾病。慢性三叉神经痛的盛行率随着年龄的增长而增加。根据世界卫生组织发布的估计，老年人口数量预计将从2015年的9亿增加到2050年的20亿。老年人更容易患糖尿病、三叉神经痛等多种疾病。

根据美国神经肌肉的资料，三叉神经痛通常发生在 50 岁以上的人身上。另据报导，女性比男性更容易患三叉神经痛。根据国际疼痛研究协会（IASP）发表的一项名为《患者的三叉神经痛之旅》的研究显示，一般人群中三叉神经痛的发生率为每10万人中3.4至5.9人。也有报道称，老年人中发病率较高。预计这些因素将在预测期内推动市场成长。立体定位放射线手术和微血管减压手术术是治疗这种疾病最常用的治疗方法。

神经疼痛治疗市场报告亮点

  • 手术细分市场将占据市场主导地位，到 2024 年将占 64.8% 的份额。对机器人放射线手术等精确和非侵入性治疗方案的需求不断增长是该领域的主要驱动力。
  • 预计在预测期内，基于药物的细分市场将以 7.0% 的最快复合年增长率增长。
  • 2024 年，医院和诊所部门占据最大的市场收益占有率。医院和诊所采用先进的非侵入性技术将透过提供更精确和有针对性的治疗来推动市场。
  • 预计门诊手术中心部分在预测期内将以最快的复合年增长率成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 神经痛治疗的变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 营商环境分析
    • 产业分析-波特五力分析
    • PESTLE分析

第四章神经痛治疗市场：依治疗的商业分析

  • 2024年及2030年治疗市场占有率
  • 治疗细分仪表板
  • 2018-2030 年市场规模、预测与趋势分析（按处理方式）
  • 基于药物的
  • 外科手术

第五章神经疼痛治疗市场：最终用途的商业分析

  • 2024 年及 2030 年最终用途市场占有率
  • 最终用途细分仪表板
  • 2018-2030 年按最终用途分類的市场规模、预测与趋势分析
  • 医院/诊所
  • 门诊手术中心
  • 其他的

第六章神经痛治疗市场：按国家分類的估计和趋势分析

  • 2024 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 参与者概览
  • 公司市场分析
  • 公司分类
  • 策略规划
  • 公司简介/上市公司
    • GSK plc.
    • Pfizer Inc.
    • Novartis AG
    • Biogen
    • Zydus Group（Cadila Healthcare Limited）
    • H. Lundbeck A/S
Product Code: GVR-4-68039-022-8

Neuralgia Treatment Market Growth & Trends:

The global neuralgia treatment market size is expected to reach USD 3.43 billion in 2030 and is projected to grow at a CAGR of 6.7% from 2025 to 2030. The rising geriatric population, increasing incidence of trigeminal neuralgia, and the growing prevalence of diabetes are the key factors driving the market. Neuralgia is a burning, stabbing, and severe pain due to a damaged or irritated nerve.

The chronic pain in the nerves can occur due to various factors such as infection, diabetes, aging, multiple sclerosis, or any similar disorders that damage the myelin sheath protecting certain nerves. Tumor compressing the trigeminal nerve can also cause the disorder. The prevalence of chronic pain in the trigeminal nerve increases with the aging population. According to the estimates published by the WHO, the geriatric population is anticipated to rise from 900.0 million in 2015 to 2.0 billion in 2050. The geriatric population is prone to many diseases such as diabetes and trigeminal neuralgia.

As per the American Association of Neuromuscular and Electrodiagnostic Medicine, the disorder usually affects the population aged 50 years or older. It also reported that women are more prone to trigeminal neuralgia than men. As per the study, The Patient's Journey Through Trigeminal Neuralgia published by the International Association for The Study of Pain (IASP), the incidence rate of the disorder in the general population is 3.4 to 5.9 per 100,000 population. It also reported that the incidence rate is comparatively higher in the geriatric population. Such factors are expected to boost market growth over the forecast period. Stereotactic radiosurgery and microvascular decompression are the two most common procedures being adopted to treat the disorder.

Neuralgia Treatment Market Report Highlights:

  • The surgery segment dominated the market and accounted for a share of 64.8% in 2024. The growing demand for precise, non-invasive treatment options, such as robotic radiosurgery, is a key driver for the segment
  • The drug-based segment is expected to grow at the fastest CAGR of 7.0% over the forecast period
  • The hospital & clinics segment accounted for the largest market revenue share in 2024. Adopting advanced, non-invasive technologies in hospitals and clinics drives the market by providing more accurate and targeted treatments
  • The ambulatory surgery centers segment is expected to grow at the fastest CAGR over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Neuralgia Treatment Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Neuralgia Treatment Market: Treatment Business Analysis

  • 4.1. Treatment Market Share, 2024 & 2030
  • 4.2. Treatment Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
  • 4.4. Drug Based
    • 4.4.1. Drug based market, 2018 - 2030 (USD Million)
    • 4.4.2. Anticonvulsant medicines
      • 4.4.2.1. Anticonvulsant medicines market, 2018 - 2030 (USD Million)
    • 4.4.3. Tricyclic antidepressants
      • 4.4.3.1. Tricyclic antidepressants market, 2018 - 2030 (USD Million)
  • 4.5. Surgery
    • 4.5.1. Surgery market, 2018 - 2030 (USD Million)
    • 4.5.2. Radiofrequency Thermal Lesioning
      • 4.5.2.1. Radiofrequency thermal lesioning market, 2018 - 2030 (USD Million)
    • 4.5.3. Stereotactic Radiosurgery
      • 4.5.3.1. Stereotactic radiosurgery market, 2018 - 2030 (USD Million)
    • 4.5.4. Microvascular Decompression
      • 4.5.4.1. Microvascular decompression market, 2018 - 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others market, 2018 - 2030 (USD Million)

Chapter 5. Neuralgia Treatment Market: End Use Business Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospital & Clinics
    • 5.4.1. Hospital & clinics market, 2018 - 2030 (USD Million)
  • 5.5. Ambulatory Surgery Centers
    • 5.5.1. Ambulatory surgery centers market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market, 2018 - 2030 (USD Million)

Chapter 6. Neuralgia Treatment Market: Country Estimates & Trend Analysis by Product and Technology

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key country dynamic
      • 6.4.2.2. Regulatory framework
      • 6.4.2.3. Competitive insights
      • 6.4.2.4. U.S. neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key country dynamic
      • 6.4.3.2. Regulatory framework
      • 6.4.3.3. Competitive insights
      • 6.4.3.4. Canada neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key country dynamic
      • 6.4.4.2. Regulatory framework
      • 6.4.4.3. Competitive insights
      • 6.4.4.4. Mexico neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key country dynamic
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive insights
      • 6.5.2.4. UK neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key country dynamic
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive insights
      • 6.5.3.4. Germany neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key country dynamic
      • 6.5.4.2. Regulatory framework
      • 6.5.4.3. Competitive insights
      • 6.5.4.4. France neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key country dynamic
      • 6.5.5.2. Regulatory framework
      • 6.5.5.3. Competitive insights
      • 6.5.5.4. Italy neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key country dynamic
      • 6.5.6.2. Regulatory framework
      • 6.5.6.3. Competitive insights
      • 6.5.6.4. Spain neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Russia
      • 6.5.7.1. Key country dynamic
      • 6.5.7.2. Regulatory framework
      • 6.5.7.3. Competitive insights
      • 6.5.7.4. Russia neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key country dynamic
      • 6.5.8.2. Regulatory framework
      • 6.5.8.3. Competitive insights
      • 6.5.8.4. Denmark neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key country dynamic
      • 6.5.9.2. Regulatory framework
      • 6.5.9.3. Competitive insights
      • 6.5.9.4. Sweden neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.10. Norway
      • 6.5.10.1. Key country dynamic
      • 6.5.10.2. Regulatory framework
      • 6.5.10.3. Competitive insights
      • 6.5.10.4. Norway neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key country dynamic
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive insights
      • 6.6.2.4. Japan neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key country dynamic
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive insights
      • 6.6.3.4. China neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key country dynamic
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive insights
      • 6.6.4.4. India neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key country dynamic
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive insights
      • 6.6.5.4. Australia neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key country dynamic
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive insights
      • 6.6.6.4. Thailand neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. South Korea
      • 6.6.7.1. Key country dynamic
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive insights
      • 6.6.7.4. South Korea neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key country dynamic
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive insights
      • 6.7.2.4. Brazil neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key country dynamic
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive insights
      • 6.7.3.4. Argentina neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key country dynamic
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive insights
      • 6.8.2.4. South Africa neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key country dynamic
      • 6.8.3.2. Regulatory framework
      • 6.8.3.3. Competitive insights
      • 6.8.3.4. Saudi Arabia neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key country dynamic
      • 6.8.4.2. Regulatory framework
      • 6.8.4.3. Competitive insights
      • 6.8.4.4. UAE neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key country dynamic
      • 6.8.5.2. Regulatory framework
      • 6.8.5.3. Competitive insights
      • 6.8.5.4. Kuwait neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. GSK plc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Product benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. Pfizer Inc.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial performance
      • 7.5.2.3. Product benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. Novartis AG
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial performance
      • 7.5.3.3. Product benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. Biogen
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial performance
      • 7.5.4.3. Product benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. Zydus Group (Cadila Healthcare Limited)
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial performance
      • 7.5.5.3. Product benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. H. Lundbeck A/S
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial performance
      • 7.5.6.3. Product benchmarking
      • 7.5.6.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global neuralgia treatment market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global neuralgia treatment market, by product, 2018 - 2030 (USD Million)
  • Table 5. Global neuralgia treatment market, by application, 2018 - 2030 (USD Million)
  • Table 6. Global neuralgia treatment market, by portability, 2018 - 2030 (USD Million)
  • Table 7. Global neuralgia treatment market, by type, 2018 - 2030 (USD Million)
  • Table 8. Global neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 9. North America neuralgia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 10. North America neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 11. North America neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 12. U.S. neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 13. U.S. Neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 14. Canada neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 15. Canada neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 16. Mexico neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 17. Mexico neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 18. Europe neuralgia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 19. Europe neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 20. Europe neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 21. UK neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 22. UK Neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 23. Germany neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 24. Germany neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 25. France neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 26. France Neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 27. Italy neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 28. Italy neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 29. Spain neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 30. Spain neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 31. Russia neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 32. Russia neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 33. Denmark neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 34. Denmark neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 35. Sweden neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 36. Sweden neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 37. Norway neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 38. Norway Neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 39. Asia Pacific neuralgia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 40. Asia Pacific neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 41. Asia Pacific neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 42. Japan neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 43. Japan neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 44. China neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 45. China neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 46. India neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 47. India neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 48. Australia neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 49. Australia neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 50. South Korea neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 51. South Korea neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 52. Thailand neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 53. Thailand neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 54. Latin America neuralgia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 55. Latin America neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 56. Latin America neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 57. Brazil neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 58. Brazil neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 59. Argentina neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 60. Argentina neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 61. Middle East & Africa Neuralgia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 62. Middle East & Africa neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 63. Middle East & Africa neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 64. South Africa neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 65. South Africa neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 66. Saudi Arabia neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 67. Saudi Arabia neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 68. UAE neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 69. UAE neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 70. Kuwait neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 71. Kuwait neuralgia treatment market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Neuralgia Treatment segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Treatment and end use outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Neuralgia treatment dynamics
  • Fig. 12 Neuralgia treatment market: Porter's five forces analysis
  • Fig. 13 Neuralgia treatment market: PESTLE analysis
  • Fig. 14 Neuralgia treatment market: Treatment segment dashboard
  • Fig. 15 Neuralgia treatment market: Treatment market share analysis, 2024 & 2030
  • Fig. 16 Drug based market, 2018 - 2030 (USD Million)
  • Fig. 17 Surgery market, 2018 - 2030 (USD Million)
  • Fig. 18 Neuralgia treatment market: End Use segment dashboard
  • Fig. 19 Neuralgia treatment market: End Use market share analysis, 2024 & 2030
  • Fig. 20 Radiofrequency thermal lesioning market, 2018 - 2030 (USD Million)
  • Fig. 21 Stereotactic radiosurgery market, 2018 - 2030 (USD Million)
  • Fig. 22 Microvascular decompression market, 2018 - 2030 (USD Million)
  • Fig. 23 Others market, 2018 - 2030 (USD Million)
  • Fig. 24 Neuralgia treatment market revenue, by region
  • Fig. 25 Regional marketplace: Key takeaways
  • Fig. 26 Regional marketplace: Key takeaways
  • Fig. 27 North America neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 28 U.S. country dynamics
  • Fig. 29 U.S. neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 30 Canada country dynamics
  • Fig. 31 Canada neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 32 Mexico country dynamics
  • Fig. 33 Mexico neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 35 UK country dynamics
  • Fig. 36 UK neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany country dynamics
  • Fig. 38 Germany neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 39 France country dynamics
  • Fig. 40 France neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy country dynamics
  • Fig. 42 Italy neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 43 Spain country dynamics
  • Fig. 44 Spain neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 45 Russia country dynamics
  • Fig. 46 Russia neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 47 Denmark country dynamics
  • Fig. 48 Denmark neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden country dynamics
  • Fig. 50 Sweden neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway country dynamics
  • Fig. 52 Norway neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 54 Japan country dynamics
  • Fig. 55 Japan neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 56 China country dynamics
  • Fig. 57 China neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 58 India country dynamics
  • Fig. 59 India neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 60 Australia country dynamics
  • Fig. 61 Australia neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand country dynamics
  • Fig. 63 Thailand neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea country dynamics
  • Fig. 65 South Korea neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil country dynamics
  • Fig. 68 Brazil neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina country dynamics
  • Fig. 70 Argentina neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 71 MEA neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 72 South Africa country dynamics
  • Fig. 73 South Africa neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 74 Saudi Arabia country dynamics
  • Fig. 75 Saudi Arabia neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 76 UAE country dynamics
  • Fig. 77 UAE neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 78 Kuwait Key country dynamics
  • Fig. 79 Kuwait neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 80 Company categorization
  • Fig. 81 Company market position analysis
  • Fig. 82 Strategic framework